North America POCT Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

In this region, North America Point-Of-Care Testing market is projected to reach USD 17,823.81 million by 2024, from USD 9,601.74 million in 2016 growing at a CAGR of 8.0% in the forecast period 2017 to 2024
Based on geography, the North America point-of-care testing market is segmented into 3 geographical regions, such as,

U.S.,
Mexico,
Canada,
North America point-of-care testing market competition by top players including –
F. Hoffmann-La Roche Ltd is going to dominate the Point-Of-Care Testing market following with Siemens AG and Abbott Laboratories, Inc., along with others such as
Beckman Coulter, Inc.,
Becton, Dickinson and Company,
Johnson & Johnson, Alere Inc.,
Instrumentation Laboratory,
PTS Diagnostics, Abaxis, Inc.,
Medtronic, Accriva Diagnostics,
OPTI Medical, Sienco, Inc.,
Alpha Scientific,
AccuBioTech Co., Ltd.,
ACON Laboratories, Inc.,
Acrongenomics, Inc.,
bioMérieux SA,
Biomerica, Inc.,
Atlas Genetics Ltd.,
Alfa Scientific Designs, Inc.,
Bio-Rad Laboratories, Inc.,
Medica Corporation,
Nova Biomedica.
The North America point-of-care testing market is segmented on the basis of product into prescription mode, distribution channel, end user, and geography.
On the basis of product, the market is segmented into 13 major segments, which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.
Cardiometabolic Monitoring Kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing. Also, infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections), and respiratory infections testing kit. Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit.
Based on prescription mode, the North America point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing.
On the basis of distribution channel, the market is segmented into direct tenders and retail.
On the basis of end users, the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory. Hospital segment is further categorized into emergency department critical-care unit, general ward, and others (intensive care unit, neo-natal). Also, clinic is segmented into physicians’ clinic and diagnostic clinic.